1-6 of 6
Mark S. Soloway
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HYAL1-v1, An Alternatively Spliced Variant of HYAL1 Hyaluronidase: A Negative Regulator of Bladder Cancer

Available to Purchase
Vinata B. Lokeshwar, Veronica Estrella, Luis Lopez, Mario Kramer, Pablo Gomez, Mark S. Soloway, Bal L. Lokeshwar
Journal: Cancer Research
Cancer Res (2006) 66 (23): 11219–11227.
https://doi.org/10.1158/0008-5472.CAN-06-1121
Published: 04 December 2006
View articletitled, HYAL1-v1, An Alternatively Spliced Variant of HYAL1 Hyaluronidase: A Negative Regulator of Bladder Cancer
Open the PDF for HYAL1-v1, An Alternatively Spliced Variant of HYAL1 Hyaluronidase: A Negative Regulator of Bladder Cancer in another window
Journal Articles

Evaluation of the Prognostic Potential of Hyaluronic Acid and Hyaluronidase (HYAL1) for Prostate Cancer

Available to Purchase
J. Timothy Posey, Mark S. Soloway, Sinan Ekici, Mario Sofer, Francisco Civantos, Robert C. Duncan, Vinata B. Lokeshwar
Journal: Cancer Research
Cancer Res (2003) 63 (10): 2638–2644.
Published: 15 May 2003
View articletitled, Evaluation of the Prognostic Potential of Hyaluronic Acid and Hyaluronidase (HYAL1) for Prostate Cancer
Open the PDF for Evaluation of the Prognostic Potential of Hyaluronic Acid and Hyaluronidase (HYAL1) for Prostate Cancer in another window
Journal Articles

Tumor-associated Hyaluronic Acid: A New Sensitive and Specific Urine Marker for Bladder Cancer

Available to Purchase
Vinata B. Lokeshwar, Can Öbek, Mark S. Soloway, Norman L. Block
Journal: Cancer Research
Cancer Res (1997) 57 (4): 773–777.
Published: 01 February 1997
View articletitled, Tumor-associated Hyaluronic Acid: A New Sensitive and Specific Urine Marker for Bladder Cancer
Open the PDF for Tumor-associated Hyaluronic Acid: A New Sensitive and Specific Urine Marker for Bladder Cancer in another window
Journal Articles

Time- and Concentration-dependent Inhibition of the Clonogenic Growth of N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced Murine Bladder Tumor Cell Lines by cis-Diamminedichloroplatinum(II)

Available to Purchase
Harvey B. Niell, Charles A. Wood, Donald D. Mickey, Mark S. Soloway
Journal: Cancer Research
Cancer Res (1982) 42 (3): 807–811.
Published: 01 March 1982
View articletitled, Time- and Concentration-dependent Inhibition of the Clonogenic Growth of N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced Murine Bladder Tumor Cell Lines by cis-Diamminedichloroplatinum(II)
Open the PDF for Time- and Concentration-dependent Inhibition of the Clonogenic Growth of N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced Murine Bladder Tumor Cell Lines by cis-Diamminedichloroplatinum(II) in another window
Journal Articles

Morphological Effects of Mitomycin C Administered Intravesically to Normal Mice and Mice with N-[4-(5-Nitro-2-furyl)-2-thiazolyl]-formamide-induced Bladder Neoplasms

Available to Purchase
Yerach Daskal, Mark S. Soloway, M. Dianne DeFuria, Stanley T. Crooke
Journal: Cancer Research
Cancer Res (1980) 40 (2): 261–267.
Published: 01 February 1980
View articletitled, Morphological Effects of Mitomycin C Administered Intravesically to Normal Mice and Mice with N-[4-(5-Nitro-2-furyl)-2-thiazolyl]-formamide-induced Bladder Neoplasms
Open the PDF for Morphological Effects of Mitomycin C Administered Intravesically to Normal Mice and Mice with N-[4-(5-Nitro-2-furyl)-2-thiazolyl]-formamide-induced Bladder Neoplasms in another window
Journal Articles

Intravesical and Systemic Chemotherapy of Murine Bladder Cancer

Available to Purchase
Mark S. Soloway
Journal: Cancer Research
Cancer Res (1977) 37 (8_Part_2): 2918–2929.
Published: 01 August 1977
View articletitled, Intravesical and Systemic Chemotherapy of Murine Bladder Cancer
Open the PDF for Intravesical and Systemic Chemotherapy of Murine Bladder Cancer in another window